RDWR Q1 2026 Earnings EPS Misses Estimates Stock Declines 298 CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses Loop Industries Q1 2026 Earnings Narrowing Losses as Company Advances Depolymerization Technology PAMT Q2 2025 Earnings Major EPS Miss Weighs on Shares Senti Biosciences Q1 2026 Earnings Narrower Loss than Expected Stock Edges Up FCBC Q1 2026 Earnings Slight EPS Miss Amid Flat Revenue Stock Inches Higher